TY - JOUR AU - Rosero, O. AU - Pantoja, D. AU - Pabón, N. AU - Ibarra, J. PY - 2021/06/14 Y2 - 2024/03/29 TI - Effectiveness of a comprehensive model of a very low-calorie diet with meal replacement and liraglutide for weight reduction in patients with obesity JF - Revista Colombiana de Endocrinología, Diabetes & Metabolismo JA - Rev.ACE VL - 7 IS - 4 SE - Original Articles DO - 10.53853/encr.7.4.650 UR - https://revistaendocrino.org/index.php/rcedm/article/view/650 SP - 244-247 AB - <p><strong><em>Introduction: </em></strong><em>In recent years, the prevalence of obesity has been growing worldwide, becoming a public health problem. Achieving a decrease in weight has become a challenge for both healthcare personnel as well as patients: a decrease of 5% to 10% in weight in obese or overweight patients has a positive impact on morbidity and mortality. This study describes the results of a therapeutic intervention program aimed at achieving weight loss in an obese population. </em></p><p><strong><em>Methodology:</em></strong> <em>a descriptive, retrospective study of a group of 63 patients who entered a comprehensive program of controlled caloric restriction, with the use of liraglutide titled, 3-month duration called The Balance Method, in the city of Pasto, Nariño, from April 2018 to December 2019. </em></p><p><strong><em>Results: </em></strong><em>77.7% were women and 22.3%, men, with a mean age of 43.4 years. On average, there was a decrease of 11.85% in body, a loss of body fat of 11.67% and a decrease in abdominal circumference of 13.2 cm; there were no statistically significant changes in lean body mass or basal metabolism. </em></p><p><strong><em>Conclusion: </em></strong><em>The proposed methodology of a comprehensive multidisciplinary caloric restriction model with the use of liraglutida may be an effective strategy for significant short-term weight loss in obese patients, without statistically significant decrease in lean mass or muscle mass. your resting metabolic rate.</em></p> ER -